Primary Sclerosing Cholangitis (PSC)

Welcome to the online home of the Chris M. Carlos and Catherine Nicole Jockisch Carlos Endowment for Primary Sclerosing Cholangitis (PSC). Thanks to support provided by this endowment, dedicated Mayo Clinic investigators and their teams are making strides to better understand and treat PSC patients, with the ultimate goal of developing a cure for this disease.

Follow the PSC page and stay up-to-date as we post news about advances in PSC research, clinical trials, and available resources.

PUBLIC PAGE

2018-10-16 PSC Group Photo

 

The Primary Sclerosing Cholangitis (PSC) research team at Mayo Clinic is comprised of a group of experts that has a combined 350-plus years of scientific and clinical experience in studying the disease. Over the past 40 years, Mayo Clinic faculty have published over 400 peer-reviewed articles about PSC. The strategic plan guiding our research endeavors is included below.

18-11-16 PSC Strategic Plan

Invite Others

Send an email to invite people you know to join the Primary Sclerosing Cholangitis (PSC) page.

We'll include this text in the user's invitation.